Cit Leads $135.6 Million Financing For Superior Biologics

Dec 01, 2022•almost 3 years ago

Amount Raised

$136 Million

PennsylvaniaBiotechnologyHealth Care

Description

CIT, a division of First Citizens Bank, today announced that its Healthcare Finance business served as lead arranger of $135.6 million in financing for Superior Biologics Inc.

Company Information

Company

Superior Biologics

Location

Pennsylvania, United States

About

Superior Biologics is a leading, independent specialty pharmacy that provides specialty drugs and home infusion therapy services. Our company offers a high-touch, patient-centric model, utilizing an affiliated network of 130+ nurses to provide highly personal care to patients. We provide advanced clinical pharmacy and nursing services across multiple therapeutic areas, including: immunology, hematology, neurology, oncology, and rheumatology. Our key focus is on immunoglobulin therapy (IVIG) for patients with immuno-deficiency and autoimmune disorders, and blood-clotting factor for patients with bleeding disorders (hemophilia). Our Mission: To inspire healthier communities by blending passionate professionals, innovative technology and unsurpassed clinical care.

Related People

Funding Insights

Based on industry data

Tech investment trends

83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech

Cit Leads $135.6 Million Financing For Superior Biologics

Description

.css-1v6jzuu{--tw-text-opacity:1;color:rgba(75, 85, 99, var(--tw-text-opacity));}Company Information

Related People

Funding Insights

Company Information